Article
type: Class

Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

Congress communication
type: Class

2012
type: Class

Generically Dependent Continuant
type: Class

Conference Paper
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-17T01:54:04
publisher: Evaluation of anti-TNF levels and anti-TNF antibodies in rheumatic diseases treated with adalimumab, etanercept and infliximab; Results from a local registry
label: RDF description of Evaluation of anti-TNF levels and anti-TNF antibodies in rheumatic diseases treated with adalimumab, etanercept and infliximab; Results from a local registry - http://research.umh.es/vivo/pub/comunicacion/127032

Evaluation of anti-TNF levels and anti-TNF antibodies in rheumatic diseases treated with adalimumab, etanercept and infliximab; Results from a local registry
type: Information Content Entity
related by: AutorExt:199905_2012-Comunicación:127032
related by: AutorExt:199907_2012-Comunicación:127032
most specific type: Congress communication
ARG_2000028: 127032 vcard
related by: AutorExt:199908_2012-Comunicación:127032
most specific type: 2012
related by: AutorExt:199904_2012-Comunicación:127032
type: Thing
type: Document
type: Congress communication
related by: AutorExt:199906_2012-Comunicación:127032
most specific type: Conference Paper
related by: Autor:4585-Comunicación:127032
type: Continuant
RO_0002353: 8TH INTERNATIONAL CONGRESS ON AUTOIMMUNITY 2012
type: Generically Dependent Continuant
type: Conference Paper
type: Entity
type: Anualidad
date time value: 127032 pubdate
type: 2012
type: Article

AutorExt:199905_2012-Comunicación:127032
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of anti-TNF levels and anti-TNF antibodies in rheumatic diseases treated with adalimumab, etanercept and infliximab; Results from a local registry

AutorExt:199907_2012-Comunicación:127032
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of anti-TNF levels and anti-TNF antibodies in rheumatic diseases treated with adalimumab, etanercept and infliximab; Results from a local registry

AutorExt:199908_2012-Comunicación:127032
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of anti-TNF levels and anti-TNF antibodies in rheumatic diseases treated with adalimumab, etanercept and infliximab; Results from a local registry

AutorExt:199904_2012-Comunicación:127032
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of anti-TNF levels and anti-TNF antibodies in rheumatic diseases treated with adalimumab, etanercept and infliximab; Results from a local registry

AutorExt:199906_2012-Comunicación:127032
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of anti-TNF levels and anti-TNF antibodies in rheumatic diseases treated with adalimumab, etanercept and infliximab; Results from a local registry

Autor:4585-Comunicación:127032
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Evaluation of anti-TNF levels and anti-TNF antibodies in rheumatic diseases treated with adalimumab, etanercept and infliximab; Results from a local registry

8TH INTERNATIONAL CONGRESS ON AUTOIMMUNITY 2012
type: Anualidad
type: BFO_0000003
RO_0002234: Evaluation of anti-TNF levels and anti-TNF antibodies in rheumatic diseases treated with adalimumab, etanercept and infliximab; Results from a local registry
type: Entity
type: BFO_0000015
type: Thing
type: Event
type: 2012
type: Conference